Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 430

1.

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.

Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G.

Mol Psychiatry. 2017 Oct 17. doi: 10.1038/mp.2017.170. [Epub ahead of print]

PMID:
29038599
2.

Widespread Volumetric Reductions in Schizophrenia and Schizoaffective Patients Displaying Compromised Cognitive Abilities.

Van Rheenen TE, Cropley V, Zalesky A, Bousman C, Wells R, Bruggemann J, Sundram S, Weinberg D, Lenroot RK, Pereira A, Shannon Weickert C, Weickert TW, Pantelis C.

Schizophr Bull. 2017 Aug 21. doi: 10.1093/schbul/sbx109. [Epub ahead of print]

PMID:
28981831
3.

Genetic variation in cytokine genes and risk for transition to psychosis among individuals at ultra-high risk.

Bousman CA, Lee TY, Kim M, Lee J, Mostaid MS, Bang M, An SK, Everall IP, Pantelis C, Kwon JS.

Schizophr Res. 2017 Sep 12. pii: S0920-9964(17)30516-9. doi: 10.1016/j.schres.2017.08.040. [Epub ahead of print] No abstract available.

PMID:
28916135
4.

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.

Di Biase MA, Zalesky A, O'keefe G, Laskaris L, Baune BT, Weickert CS, Olver J, McGorry PD, Amminger GP, Nelson B, Scott AM, Hickie I, Banati R, Turkheimer F, Yaqub M, Everall IP, Pantelis C, Cropley V.

Transl Psychiatry. 2017 Aug 29;7(8):e1225. doi: 10.1038/tp.2017.193.

5.

Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.

Bousman CA, Cropley V, Klauser P, Hess JL, Pereira A, Idrizi R, Bruggemann J, Mostaid MS, Lenroot R, Weickert TW, Glatt SJ, Everall IP, Sundram S, Zalesky A, Weickert CS, Pantelis C.

Psychol Med. 2017 Aug 22:1-9. doi: 10.1017/S0033291717002173. [Epub ahead of print]

PMID:
28826413
6.

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.

Saini SM, Mancuso SG, Mostaid MS, Liu C, Pantelis C, Everall IP, Bousman CA.

Transl Psychiatry. 2017 Aug 8;7(8):e1196. doi: 10.1038/tp.2017.172.

7.

Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.

Bousman CA, Jaksa P, Pantelis C.

Pharmacogenet Genomics. 2017 Nov;27(11):387-393. doi: 10.1097/FPC.0000000000000303.

PMID:
28777243
8.

Risk and resilience brain networks in treatment-resistant schizophrenia.

Ganella EP, Seguin C, Bartholomeusz CF, Whittle S, Bousman C, Wannan CMJ, Di Biase MA, Phassouliotis C, Everall I, Pantelis C, Zalesky A.

Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30415-2. doi: 10.1016/j.schres.2017.07.014. [Epub ahead of print]

PMID:
28735641
9.

Ventricular volumes across stages of schizophrenia and other psychoses.

Berger GE, Bartholomeusz CF, Wood SJ, Ang A, Phillips LJ, Proffitt T, Brewer WJ, Smith DJ, Nelson B, Lin A, Borgwardt S, Velakoulis D, Yung AR, McGorry PD, Pantelis C.

Aust N Z J Psychiatry. 2017 Oct;51(10):1041-1051. doi: 10.1177/0004867417715914. Epub 2017 Jul 1.

PMID:
28670977
10.

Role of Positive Parenting in the Association Between Neighborhood Social Disadvantage and Brain Development Across Adolescence.

Whittle S, Vijayakumar N, Simmons JG, Dennison M, Schwartz O, Pantelis C, Sheeber L, Byrne ML, Allen NB.

JAMA Psychiatry. 2017 Aug 1;74(8):824-832. doi: 10.1001/jamapsychiatry.2017.1558.

PMID:
28636697
11.

Deterioration of visuospatial associative memory following a first psychotic episode: a long-term follow-up study.

Wannan CMJ, Bartholomeusz CF, Cropley VL, Van Rheenen TE, Panayiotou A, Brewer WJ, Proffitt TM, Henry L, Harris MG, Velakoulis D, McGorry P, Pantelis C, Wood SJ.

Psychol Med. 2017 Jun 19:1-10. doi: 10.1017/S003329171700157X. [Epub ahead of print]

PMID:
28625185
12.

White matter connectivity disruptions in early and chronic schizophrenia.

Di Biase MA, Cropley VL, Baune BT, Olver J, Amminger GP, Phassouliotis C, Bousman C, McGorry PD, Everall I, Pantelis C, Zalesky A.

Psychol Med. 2017 May 22:1-14. doi: 10.1017/S0033291717001313. [Epub ahead of print]

PMID:
28528586
13.

Attentional set-shifting and social abilities in children with schizotypal and comorbid autism spectrum disorders.

Abu-Akel A, Testa RR, Jones HP, Ross N, Skafidas E, Tonge B, Pantelis C.

Aust N Z J Psychiatry. 2017 May 1:4867417708610. doi: 10.1177/0004867417708610. [Epub ahead of print]

PMID:
28523937
14.

Can we raise the standard of care in treating schizophrenia: A cautionary note!

Jayaram M, Hopwood M, Pantelis C.

Aust N Z J Psychiatry. 2017 Jun;51(6):557-559. doi: 10.1177/0004867417698232. Epub 2017 Mar 15. No abstract available.

PMID:
28521536
15.

Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging.

Kamagata K, Zalesky A, Hatano T, Ueda R, Di Biase MA, Okuzumi A, Shimoji K, Hori M, Caeyenberghs K, Pantelis C, Hattori N, Aoki S.

Hum Brain Mapp. 2017 May 4. doi: 10.1002/hbm.23628. [Epub ahead of print]

PMID:
28470878
16.

The effects of stress-tension on depression and anxiety symptoms: evidence from a novel twin modelling analysis.

Davey CG, López-Solà C, Bui M, Hopper JL, Pantelis C, Fontenelle LF, Harrison BJ.

Psychol Med. 2017 Jul;47(10):1865. doi: 10.1017/S003329171700037X. Epub 2017 Apr 11. No abstract available.

PMID:
28395675
17.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

18.

Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial.

Berk M, Daglas R, Dandash O, Yücel M, Henry L, Hallam K, Macneil C, Hasty M, Pantelis C, Murphy BP, Kader L, Damodaran S, Wong MTH, Conus P, Ratheesh A, McGorry PD, Cotton SM.

Br J Psychiatry. 2017 Jun;210(6):413-421. doi: 10.1192/bjp.bp.116.186833. Epub 2017 Mar 2.

PMID:
28254958
19.

Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.

Van Rheenen TE, Lewandowski KE, Tan EJ, Ospina LH, Ongur D, Neill E, Gurvich C, Pantelis C, Malhotra AK, Rossell SL, Burdick KE.

Psychol Med. 2017 Jul;47(10):1848-1864. doi: 10.1017/S0033291717000307. Epub 2017 Feb 28.

PMID:
28241891
20.

Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations.

Liu C, Bousman CA, Pantelis C, Skafidas E, Zhang D, Yue W, Everall IP.

Transl Psychiatry. 2017 Feb 21;7(2):e1037. doi: 10.1038/tp.2017.8.

Supplemental Content

Loading ...
Support Center